Collaboration Between CEA and FLASH THERAPEUTICS for the Development of Cutaneous Cell Therapy

Contributed by: Business Wire

Logo

Tags

Research

Genetics

Biotechnology

Other Health

Health

General Health

Other Science

Science

Oncology

CEA

More Like This

CEA & Dawex Create a Joint Research & Development Laboratory to Advance Innovation in Industries

Egle Therapeutics Receives €9.3 Million in State Funding Under the “Innovations in Biotherapies and Bioproduction” Call for Projects from France 2030

Egle Therapeutics Strengthens its Executive Leadership Team With the Appointment of Christophe Quéva, Ph.D., as Chief Executive Officer

PR Newswire associated0

THERYQ and Gustave Roussy have been selected as part of the "i-Démo" France 2030 call for projects, operated on behalf of the French government by Bpifrance, for the "FLASHDEEP" project, for an amount of 38 million euros

Alexandre Bounouh, Director of the CEA-List Institute, specialising in smart digital systems, and Bertrand Tavernier, CTO for Thales’s Secure Communications and Information Systems business, at the signing of the partnership agreement on 30 April 2024 in Palaiseau, France. (Photo: Thales)

Thales and CEA Partner on Trusted Generative AI for Defence and Security

PR Newswire associated0

THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR)

PR Newswire associated0

Mallinckrodt Presents Data on Real-World Outcomes with THERAKOS™ CELLEX™ Photopheresis System Treatment at the 2024 Tandem Meetings

EpilepsyGTx announces a $10M fundraise to complete the CTA-enabling nonclinical package for lead program EPY201